PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION

Carregando...
Imagem de Miniatura
CitaçÔes na Scopus
3
Tipo de produção
article
Data de publicação
2019
Editora
ATHA COMUNICACAO & EDITORA
Indexadores
TĂ­tulo da Revista
ISSN da Revista
TĂ­tulo do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ACTA ORTOPEDICA BRASILEIRA, v.27, n.2, p.95-99, 2019
Projetos de Pesquisa
Unidades Organizacionais
FascĂ­culo
Resumo
Objective: To evaluate the epidemiological profile of patients with osteoporotic fractures compared to patients with osteoarthritis (OA) and identify factors that diminish adherence to secondary prevention. Methods: A total of 108 patients with osteoporotic fractures (OF) were compared to 86 patients with OA. Results: Patients in the OF group were older (p < 0.001); had a lower body mass index (p < 0.001); were less literate (p = 0.012); were more frequently Caucasian (p = 0.003); were less frequently married (p < 0.001); experienced more falls, cognitive deficiency, previous fractures, old fracture, falls in the last year, and fall fractures; needed more help and took more medicine for osteoporosis (p < 0.05); and showed less pathology in the feet, muscle weakness, less vitamin D intake, and lower Katz & Lawton scores (p < 0.001). Factors that increased the chance of nonadherence included older age (p = 0.020), falls (p = 0.035), cognitive deficiency (p = 0.044), and presence of depression/apathy/confusion (p < 0.001). Conclusion: Patient age, ethnicity, marital status, previous falls, foot pathologies, muscle weakness, previous fractures, use of vitamin D, use of osteoporosis drugs, and lower Katz & Lawton scale score defined the OF group. Factors that increased the chance of nonadherence included older age, sedative use, cognitive disorders, and symptoms of depression/apathy/confusion.
Objetivo: Avaliar o perfil epidemiolĂłgico de pacientes com fraturas osteoporĂłticas, comparando com pacientes com osteoartrite (OA) e identificar fatores que diminuam aderĂȘncia Ă  prevenção secundĂĄria. MĂ©todos: 108 pacientes com FO foram comparados a 86 pacientes com OA. Resultados: Grupo FO era mais velho (p< 0,001), com menor IMC (p<0,001), menos alfabetizado (p = 0,012), com maior frequĂȘncia de brancos (p = 0,003), menor frequĂȘncia de casados (p< 0,001). Apresentaram mais quedas, deficiĂȘncia cognitiva, fraturas prĂ©vias, fratura antiga, queda no Ășltimo ano, fraturas por queda. Necessitam de mais auxĂ­lio e tomam mais medicamento para osteoporose (p< 0,05); apresentaram menos patologia nos pĂ©s, fraqueza muscular. Tomam menos vitamina D e menor Katz & Lawton (p<0,001). Tem aumento da chance de nĂŁo aderĂȘncia: maior idade (p = 0,020), sedativo (p = 0,020), quedas (p = 0,035), deficiĂȘncia cognitiva (p = 0,044) e presença de depressĂŁo/apatia/confusĂŁo (p< 0,001). ConclusĂŁo: Idade do paciente, etnia, estado civil, quedas prĂ©vias, patologias nos pĂ©s, fraqueza muscular, fraturas prĂ©vias, uso de vitamina D, uso de medicamentos para osteoporose e a escala Katz & Lawton definem o grupo FO. Aumentam a chance de nĂŁo aderĂȘncia: maior idade, sedativos, distĂșrbios cognitivos e sintomas de depressĂŁo/apatia/confusĂŁo. NĂ­vel de EvidĂȘncia III, Estudo de caso controle.
Palavras-chave
Osteoporotic Fractures, Osteoporosis, Epidemiology, Prevalence, Secondary Prevention, Fraturas por osteoporose, Osteoporose, Epidemiologia, PrevalĂȘncia
ReferĂȘncias
  1. Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072
  2. Duarte YAD, 2007, REV ESC ENFERM USP, V41, P317, DOI 10.1590/S0080-62342007000200021
  3. de Rezende MU, 2017, ACTA ORTOP BRAS, V25, P18, DOI 10.1590/1413-785220172501165604
  4. Gold DT, 2001, RHEUM DIS CLIN N AM, V27, P255, DOI 10.1016/S0889-857X(05)70197-6
  5. Grinberg Plapler P, 2014, J OSTEOPOR PHYS ACT, V2, P118
  6. Hawley S, 2016, AGE AGEING, V45, P236, DOI 10.1093/ageing/afv204
  7. Huntjens Kirsten M B, 2014, J Bone Joint Surg Am, V96, pe29, DOI 10.2106/JBJS.L.00223
  8. Javaid MK, 2015, OSTEOPOROSIS INT, V26, P2573, DOI 10.1007/s00198-015-3192-0
  9. Judge A, 2016, MODELS CARE DELIVERY
  10. Kanis JA, 2017, OSTEOPOROSIS INT, V28, P2023, DOI 10.1007/s00198-017-4009-0
  11. Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024
  12. Kerr C, 2017, OSTEOPOROSIS INT, V28, P1597, DOI 10.1007/s00198-017-3911-9
  13. Kinds MB, 2010, BON HLTH OST REP SUR
  14. LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9
  15. Mitchell P, 2016, BEST PRACT RES CL RH, V30, P536, DOI 10.1016/j.berh.2016.09.008
  16. Moraes Luci Fabiane Scheffer, 2014, Rev. bras. epidemiol., V17, P719, DOI 10.1590/1809-4503201400030012
  17. Pinheiro MM, 2012, OSTEOPOROSIS INT, V23, P1371, DOI 10.1007/s00198-011-1722-y
  18. Shu MM, 2018, ACTA ORTOP BRAS, V26, P117, DOI 10.1590/1413-785220182602185325
  19. Tran T, 2017, J BONE MINER RES, V32, P1802, DOI 10.1002/jbmr.3118
  20. Zerbini CAF, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0224-5